Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia

Abdul Rahman El Kinge; Hassan A. Hatoum; Rami A. Mahfouz; Zaher K. Otrock; Elias Jabbour; Hagop Kantarjian; Ali Bazarbachi

doi:10.1016/j.leukres.2008.05.006

Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia

Abdul Rahman El Kinge, Hassan A. Hatoum, Rami A. Mahfouz, Zaher K. Otrock, Elias Jabbour, Hagop Kantarjian, Ali Bazarbachi

Leukemia

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	565-566
Number of pages	2
Journal	Leukemia Research
Volume	33
Issue number	4
DOIs	https://doi.org/10.1016/j.leukres.2008.05.006
State	Published - Apr 2009

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.leukres.2008.05.006

Cite this

@article{e42ea3684e4b42f68e18c5adaf33c2d8,

title = "Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia",

author = "{El Kinge}, {Abdul Rahman} and Hatoum, {Hassan A.} and Mahfouz, {Rami A.} and Otrock, {Zaher K.} and Elias Jabbour and Hagop Kantarjian and Ali Bazarbachi",

year = "2009",

month = apr,

doi = "10.1016/j.leukres.2008.05.006",

language = "English (US)",

volume = "33",

pages = "565--566",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Limited",

number = "4",

}

TY - JOUR

T1 - Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia

AU - El Kinge, Abdul Rahman

AU - Hatoum, Hassan A.

AU - Mahfouz, Rami A.

AU - Otrock, Zaher K.

AU - Jabbour, Elias

AU - Kantarjian, Hagop

AU - Bazarbachi, Ali

PY - 2009/4

Y1 - 2009/4

UR - http://www.scopus.com/inward/record.url?scp=60249093271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60249093271&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2008.05.006

DO - 10.1016/j.leukres.2008.05.006

M3 - Letter

C2 - 18571231

AN - SCOPUS:60249093271

SN - 0145-2126

VL - 33

SP - 565

EP - 566

JO - Leukemia Research

JF - Leukemia Research

IS - 4

ER -

Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this